68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional study

DISCUSSION: Our findings demonstrate that PSMA PET/MRI is a better imaging modality in the detection of disease in the setting of BCR when compared to MRI alone. Combined utility with PSMA PET/MRI is a powerful tool which can aid in not only the detection of disease, but also guide in treatment planning for prostate cancer patients.PMID:34649151 | DOI:10.1016/j.tranon.2021.101242

Source: Translational Oncology - October 14, 2021 Category: Cancer & Oncology Authors: Juana Martinez Kritika Subramanian Daniel Margolis Elisabeth O'Dwyer Joseph Osborne Yuliya Jhanwar Himanshu Nagar Nicholas Williams Arindam RoyChoudhury Gabriela Madera John Babich Sandra Huicochea Castellanos Source Type: research